|FY2021 Flash Grant Cycle 1
Flash Grants infuse funding at a critical early point when a small, targeted influx of funds can be crucial to shaping innovative research ideas into high potential life sciences technologies, particularly in emerging and converging life sciences sectors. Up to $20,000 may be requested for short, highly focused projects.
Cycle 1 is a targeted round and is open only to projects in these areas:
– Novel antibiotics and therapeutics targeting antibiotic-resistant bacteria
– Global Coronavirus disease (COVID-19) outbreak – COVID-19-specific therapies, vaccine development, diagnosis, and epidemiology
Flash Grants support short, tightly focused research projects in these two categories:
1. To obtain crucial proof-of-concept or feasibility testing data necessary to suggest the disruptive potential of a life sciences technology, and/or
2. To conduct the final experiment(s) needed to advance a basic life sciences research program into the translational research phase of development
Details are in the guidelines, posted at www.ncbiotech.org/flash.